ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,433.74
0.23%
US Tech 100
19,068.80
0.00%
Dow Jones
38,647.10
-0.17%
Brent Oil
82.17
0.24%
Bitcoin
66,996.19
0.36%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/14/20243:15AMGlobeNewswire Inc.HSBC Bank plc: Post Stabilisation Notice
06/14/20243:15AMPR Newswire (Canada)Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.
06/14/20243:15AMPR Newswire (US)Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.
06/14/20243:11AMGlobeNewswire Inc.Early Signals by WOO X: BTC Faces Downward Trend While TON Ecosystem Reaches New Highs with Surging Market Interest
06/14/20243:06AMGlobeNewswire Inc.Nikkiso Clean Energy & Industrial Gases Group anuncia transición de director ejecutivo para el día 1ro. de julio de 2024
06/14/20243:06AMGlobeNewswire Inc.Nikkiso Clean Energy & Industrial Gases Group Anuncia Transição de CEO para o dia 1º de julho de 2024
06/14/20243:06AMGlobeNewswire Inc.Le groupe Nikkiso Clean Energy & Industrial Gases annonce un changement de direction au 1er juillet 2024
06/14/20243:06AMGlobeNewswire Inc.Nikkiso Clean Energy & Industrial Gases Group kündigt Wechsel des CEO zum 1. Juli 2024 an
06/14/20243:05AMGlobeNewswire Inc.Zefiro Publishes “Letter from the CEO” Following its Inaugural Earnings ReportNEO:ZEFIZefiro Methane Corp
06/14/20243:05AMGlobeNewswire Inc.Zefiro Publishes “Letter from the CEO” Following its Inaugural Earnings ReportY6B
06/14/20243:05AMPR Newswire (US)Rigel Announces Five Presentations at the EHA2024 Hybrid CongressNASDAQ:RIGLRigel Pharmaceuticals Inc
06/14/20243:03AMBusiness WireVertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the 2024 Annual European Hematology Association (EHA) CongressNASDAQ:VRTXVertex Pharmaceuticals Inc
06/14/20243:02AMGlobeNewswire Inc.Flash News: OKX Announces Exclusive Minting of Slerf NFTs on its Marketplace
06/14/20243:01AMPR Newswire (US)The Safavi Impact Institute Sponsors NASA's Space Center Houston's pilot education program in Austria
06/14/20243:01AMPR Newswire (US)MSC Cruises launches first Tea Library at sea to create perfect cuppa from home for Brits
06/14/20243:01AMGlobeNewswire Inc.Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease, Presented at the European Hematology Association (EHA) Annual CongressNASDAQ:EDITEditas Medicine Inc
06/14/20243:00AMBusiness WireELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple MyelomaNYSE:PFEPfizer Inc
06/14/20243:00AMGlobeNewswire Inc.Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investigational Base Editing Therapeutic for Sickle Cell DiseaseNASDAQ:BEAMBeam Therapeutics Inc
06/14/20243:00AMGlobeNewswire Inc.Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patients with Transfusion-dependent Beta Thalassemia, Presented at the European Hematology Association (EHA) Annual CongressNASDAQ:EDITEditas Medicine Inc
06/14/20243:00AMBusiness WireImmune-Onc Therapeutics to Present Additional Positive Interim Data from IO-202 Phase 1b Expansion Cohort in Patients with Chronic Myelomonocytic Leukemia (CMML) at 2024 European Hematology Association (EHA) Annual Congress
06/14/20243:00AMBusiness WireNew Kite Clinical Research and Real-World Evidence for Yescarta® Demonstrate Benefit From Earlier Lines of TreatmentNASDAQ:GILDGilead Sciences Inc
06/14/20243:00AMGlobeNewswire Inc.Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimilar), at the European Hematology Association (EHA) Congress 2024
06/14/20243:00AMPR Newswire (US)Brickken is selected to participate in the European Blockchain Regulatory Sandbox
06/14/20243:00AMPR Newswire (US)Top tips for retail store remodeling from the Paso Robles general contractor
06/14/20243:00AMPR Newswire (US)Protecting the vulnerable--Atascadero estate planning attorney on guardianships and conservatorships
06/14/20243:00AMPR Newswire (US)Brickken is selected to participate in the European Blockchain Regulatory Sandbox
06/14/20243:00AMPR Newswire (US)Getting a divorce when a spouse is missing, tips from We Help You Legal
06/14/20242:46AMAlliance NewsAlliance NewsLONDON BRIEFING: Bellway's planned takeover of Crest gets rejected
06/14/20242:46AMAlliance NewsAlliance NewsBridgerton boosts UK economy by GBP275 million, Netflix saysLSE:0QYINetflix Inc
06/14/20242:46AMPR Newswire (US)Expats soak up Duanwu fun in Shandong

Your Recent History

BIT
P1D9X1
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved